vs

Side-by-side financial comparison of Roivant Sciences Ltd. (ROIV) and US ENERGY CORP (USEG). Click either name above to swap in a different company.

Roivant Sciences Ltd. is the larger business by last-quarter revenue ($2.0M vs $1.7M, roughly 1.2× US ENERGY CORP). US ENERGY CORP runs the higher net margin — -192.2% vs -13301.2%, a 13109.0% gap on every dollar of revenue. On growth, US ENERGY CORP posted the faster year-over-year revenue change (-64.9% vs -77.8%). Over the past eight quarters, US ENERGY CORP's revenue compounded faster (-51.3% CAGR vs -73.7%).

Roivant Sciences Ltd. is an American multinational healthcare company focused on applying technology to drug development and building subsidiary life sciences and health technology companies. It was founded in 2014 by Vivek Ramaswamy and is currently headed by CEO Matt Gline. Roivant maintains its headquarters in New York City as well as major offices in the biotech hubs of Boston and Basel.

NextEra Energy, Inc. is an American energy company that is the world's largest electric utility holding company by market capitalization, with a valuation of over $170 billion as of Oct 2024. NextEra Energy had revenues of $24.8 billion and 16,700 employees throughout the US and Canada in 2024. It has a current generating capacity of 73 gigawatts. Its subsidiaries include Florida Power & Light (FPL), NextEra Energy Resources (NEER), XPLR Energy Partners, and NextEra Energy Services.

ROIV vs USEG — Head-to-Head

Bigger by revenue
ROIV
ROIV
1.2× larger
ROIV
$2.0M
$1.7M
USEG
Growing faster (revenue YoY)
USEG
USEG
+12.9% gap
USEG
-64.9%
-77.8%
ROIV
Higher net margin
USEG
USEG
13109.0% more per $
USEG
-192.2%
-13301.2%
ROIV
Faster 2-yr revenue CAGR
USEG
USEG
Annualised
USEG
-51.3%
-73.7%
ROIV

Income Statement — Q3 FY2026 vs Q3 FY2025

Metric
ROIV
ROIV
USEG
USEG
Revenue
$2.0M
$1.7M
Net Profit
$-265.9M
$-3.3M
Gross Margin
Operating Margin
-16966.1%
-194.4%
Net Margin
-13301.2%
-192.2%
Revenue YoY
-77.8%
-64.9%
Net Profit YoY
-257.0%
-48.7%
EPS (diluted)
$-0.38

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ROIV
ROIV
USEG
USEG
Q4 25
$2.0M
Q3 25
$1.6M
$1.7M
Q2 25
$2.2M
$2.0M
Q1 25
$-39.6M
$2.2M
Q4 24
$9.0M
$4.2M
Q3 24
$4.5M
$5.0M
Q2 24
$8.0M
$6.0M
Q1 24
$28.9M
$5.4M
Net Profit
ROIV
ROIV
USEG
USEG
Q4 25
$-265.9M
Q3 25
$-113.5M
$-3.3M
Q2 25
$-223.4M
$-6.1M
Q1 25
$-206.5M
$-3.1M
Q4 24
$169.4M
Q3 24
$-230.2M
$-2.2M
Q2 24
$95.3M
$-2.0M
Q1 24
$-151.1M
$-9.5M
Operating Margin
ROIV
ROIV
USEG
USEG
Q4 25
-16966.1%
Q3 25
-19492.9%
-194.4%
Q2 25
-13130.0%
-307.6%
Q1 25
674.8%
-140.8%
Q4 24
-3042.6%
-278.9%
Q3 24
-7636.0%
-83.8%
Q2 24
-1279.5%
-28.4%
Q1 24
-919.5%
-148.8%
Net Margin
ROIV
ROIV
USEG
USEG
Q4 25
-13301.2%
Q3 25
-7225.9%
-192.2%
Q2 25
-10292.9%
-298.7%
Q1 25
521.8%
-141.9%
Q4 24
1878.3%
Q3 24
-5143.8%
-45.3%
Q2 24
1192.7%
-32.6%
Q1 24
-522.3%
-176.9%
EPS (diluted)
ROIV
ROIV
USEG
USEG
Q4 25
$-0.38
Q3 25
$-0.17
Q2 25
$-0.33
$-0.19
Q1 25
$-0.28
Q4 24
$0.23
$-0.42
Q3 24
$-0.31
$-0.08
Q2 24
$0.12
$-0.08
Q1 24
$-0.02
$-0.38

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ROIV
ROIV
USEG
USEG
Cash + ST InvestmentsLiquidity on hand
$4.5B
$1.7M
Total DebtLower is stronger
Stockholders' EquityBook value
$4.3B
$25.0M
Total Assets
$5.2B
$46.5M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ROIV
ROIV
USEG
USEG
Q4 25
$4.5B
Q3 25
$4.4B
$1.7M
Q2 25
$4.5B
$6.9M
Q1 25
$4.9B
$10.6M
Q4 24
$5.1B
$7.9M
Q3 24
$5.4B
$1.3M
Q2 24
$5.7B
$2.4M
Q1 24
$6.5B
$2.2M
Total Debt
ROIV
ROIV
USEG
USEG
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
$311.7M
Q1 24
$430.6M
Stockholders' Equity
ROIV
ROIV
USEG
USEG
Q4 25
$4.3B
Q3 25
$4.4B
$25.0M
Q2 25
$4.3B
$28.0M
Q1 25
$4.7B
$33.6M
Q4 24
$5.2B
$24.2M
Q3 24
$5.2B
$35.7M
Q2 24
$5.4B
$37.7M
Q1 24
$6.0B
$36.7M
Total Assets
ROIV
ROIV
USEG
USEG
Q4 25
$5.2B
Q3 25
$5.1B
$46.5M
Q2 25
$5.0B
$51.0M
Q1 25
$5.4B
$55.8M
Q4 24
$5.8B
$49.7M
Q3 24
$6.2B
$64.1M
Q2 24
$6.5B
$73.7M
Q1 24
$7.2B
$70.3M
Debt / Equity
ROIV
ROIV
USEG
USEG
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
0.06×
Q1 24
0.07×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ROIV
ROIV
USEG
USEG
Operating Cash FlowLast quarter
$-196.5M
$-155.0K
Free Cash FlowOCF − Capex
$-201.4M
FCF MarginFCF / Revenue
-10076.0%
Capex IntensityCapex / Revenue
246.9%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-776.7M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ROIV
ROIV
USEG
USEG
Q4 25
$-196.5M
Q3 25
$-185.7M
$-155.0K
Q2 25
$-204.4M
$-1.6M
Q1 25
$-172.6M
$-4.5M
Q4 24
$-207.3M
$1.7M
Q3 24
$-266.8M
$2.6M
Q2 24
$-192.8M
$929.0K
Q1 24
$-108.5M
$-603.0K
Free Cash Flow
ROIV
ROIV
USEG
USEG
Q4 25
$-201.4M
Q3 25
$-193.5M
Q2 25
$-208.4M
Q1 25
$-173.4M
Q4 24
$-209.1M
Q3 24
$-267.8M
Q2 24
$-193.8M
Q1 24
$-108.8M
FCF Margin
ROIV
ROIV
USEG
USEG
Q4 25
-10076.0%
Q3 25
-12317.8%
Q2 25
-9604.5%
Q1 25
438.1%
Q4 24
-2318.5%
Q3 24
-5984.4%
Q2 24
-2425.5%
Q1 24
-376.1%
Capex Intensity
ROIV
ROIV
USEG
USEG
Q4 25
246.9%
Q3 25
499.6%
Q2 25
185.9%
Q1 25
-2.0%
Q4 24
20.3%
Q3 24
22.3%
Q2 24
12.1%
Q1 24
1.2%
Cash Conversion
ROIV
ROIV
USEG
USEG
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
-1.22×
Q3 24
Q2 24
-2.02×
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ROIV
ROIV

Segment breakdown not available.

USEG
USEG

Oil Sales$1.6M91%
Other$151.0K9%

Related Comparisons